JP2024501839A - 腸管洗浄用の経口固形製剤 - Google Patents

腸管洗浄用の経口固形製剤 Download PDF

Info

Publication number
JP2024501839A
JP2024501839A JP2023539331A JP2023539331A JP2024501839A JP 2024501839 A JP2024501839 A JP 2024501839A JP 2023539331 A JP2023539331 A JP 2023539331A JP 2023539331 A JP2023539331 A JP 2023539331A JP 2024501839 A JP2024501839 A JP 2024501839A
Authority
JP
Japan
Prior art keywords
solid preparation
sulfate
less
oral solid
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023539331A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024501839A5 (cg-RX-API-DMAC7.html
Inventor
イ，ジュンヨブ
グ，ワン
チャン，ウヨン
キム，ヨンウン
キム，ヨンジュン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taejoon Pharmaceutical Co Ltd
Original Assignee
Taejoon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taejoon Pharmaceutical Co Ltd filed Critical Taejoon Pharmaceutical Co Ltd
Publication of JP2024501839A publication Critical patent/JP2024501839A/ja
Publication of JP2024501839A5 publication Critical patent/JP2024501839A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023539331A 2020-12-31 2021-12-30 腸管洗浄用の経口固形製剤 Pending JP2024501839A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR10-2020-0189688 2020-12-31
KR20200189689 2020-12-31
KR10-2020-0189689 2020-12-31
KR20200189688 2020-12-31
PCT/KR2021/020327 WO2022146089A1 (ko) 2020-12-31 2021-12-30 장세척을 위한 경구용 고형제제

Publications (2)

Publication Number Publication Date
JP2024501839A true JP2024501839A (ja) 2024-01-16
JP2024501839A5 JP2024501839A5 (cg-RX-API-DMAC7.html) 2024-12-26

Family

ID=82259801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023539331A Pending JP2024501839A (ja) 2020-12-31 2021-12-30 腸管洗浄用の経口固形製剤

Country Status (6)

Country Link
US (1) US20240075060A1 (cg-RX-API-DMAC7.html)
EP (1) EP4272734A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024501839A (cg-RX-API-DMAC7.html)
KR (2) KR102669683B1 (cg-RX-API-DMAC7.html)
CA (1) CA3202758A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022146089A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102635438B1 (ko) * 2022-10-07 2024-02-13 주식회사태준제약 장 세척을 위한 고형제제 및 이의 제조방법
TW202508608A (zh) * 2023-05-12 2025-03-01 南韓商法姆拜歐韓國股份有限公司 結腸緩瀉錠劑及包含彼之結腸緩瀉劑
WO2025259039A1 (ko) * 2024-06-13 2025-12-18 주식회사태준제약 장정결을 위한 고형제제

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000299A1 (en) * 2001-06-25 2003-01-03 Colocaps Pty Ltd Laxative preparation
JP2008115085A (ja) * 2006-11-01 2008-05-22 Tendou Seiyaku Kk 緩下剤
US20130189377A1 (en) * 2010-07-27 2013-07-25 Norgine Bv Compositions
KR20190041233A (ko) * 2017-10-12 2019-04-22 주식회사 한국팜비오 황산염을 포함하는 대장 하제 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE277739T1 (de) * 1996-10-28 2004-10-15 Gen Mills Inc Einbettung und einkapselung von teilchen zur kontrollierten abgabe
WO2007099398A2 (en) * 2005-09-27 2007-09-07 Naturalite Benelux B.V. Methods and compositions for treatment of skin
BR112013014827A2 (pt) * 2010-12-13 2016-10-04 Antony Wettstein formulações gástricas e colônicas e métodos para produzir e usar as mesmas
KR20140044628A (ko) * 2012-10-05 2014-04-15 주식회사태준제약 신규한 폴리에틸렌글리콜과 비타민 씨를 함유하는 안정성이 개선된 장관 하제 조성물
KR101423005B1 (ko) * 2013-10-17 2014-07-28 강윤식 장 세정용 조성물
KR101659746B1 (ko) * 2014-01-28 2016-09-26 주식회사한국파마 황산염을 함유하는 장관 하제 조성물 및 이의 제조 방법
KR20180091572A (ko) * 2017-02-07 2018-08-16 주식회사 한국팜비오 경구투여용 대장하제조성물
KR20190093490A (ko) * 2018-02-01 2019-08-09 주식회사태준제약 장세척 조성물
KR102111094B1 (ko) * 2018-06-18 2020-05-14 주식회사 한국팜비오 무수황산나트륨, 황산칼륨, 무수황산마그네슘 및 시메티콘을 포함하는 장관하제 경구투여용 고형제제 조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000299A1 (en) * 2001-06-25 2003-01-03 Colocaps Pty Ltd Laxative preparation
JP2008115085A (ja) * 2006-11-01 2008-05-22 Tendou Seiyaku Kk 緩下剤
US20130189377A1 (en) * 2010-07-27 2013-07-25 Norgine Bv Compositions
KR20190041233A (ko) * 2017-10-12 2019-04-22 주식회사 한국팜비오 황산염을 포함하는 대장 하제 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OPEN JOURNAL OF CHEMISTRY, vol. 3(1), JPN7025004224, 25 July 2017 (2017-07-25), pages 012 - 022, ISSN: 0005855872 *

Also Published As

Publication number Publication date
KR102669683B1 (ko) 2024-05-28
EP4272734A4 (en) 2024-12-04
EP4272734A1 (en) 2023-11-08
KR20220097340A (ko) 2022-07-07
US20240075060A1 (en) 2024-03-07
WO2022146089A1 (ko) 2022-07-07
CA3202758A1 (en) 2022-07-07
KR20230043086A (ko) 2023-03-30

Similar Documents

Publication Publication Date Title
US6723340B2 (en) Optimal polymer mixtures for gastric retentive tablets
ES2584866T3 (es) Composición purgante para el colon con agente aglutinante soluble
US9492541B2 (en) Phenylepherine containing dosage form
KR102669683B1 (ko) 장세척을 위한 경구용 고형제제
AU2002337974A1 (en) Optimal polymer mixtures for gastric retentive tablets
JP3633936B2 (ja) センナ剤形
CN100389751C (zh) 含扑热息痛的吞咽片剂
JP5879359B2 (ja) クエン酸及び重炭酸塩を含んでなる医薬組成物、並びにシスチン尿症を治療するためのこれらの使用
CN112292136A (zh) 口服给药含无水硫酸钠、硫酸钾、无水硫酸镁和西甲硅油的结肠泻药的固体制剂组合物
JP2008285434A (ja) 口腔内速崩壊錠
CA2870130A1 (en) Compositions and methods for treating cough
CZ301449B6 (cs) Léková forma
WO2005060941A1 (en) Extended release antibiotic composition
US20130230590A1 (en) Pharmaceutical composition comprising bicarbonate salt, and use thereof as a medicament in the treatment and/or prevention of urinary lithiases and related diseases
JPH08295637A (ja) 口腔部局所投与剤
KR20090086128A (ko) 메만틴 약학 조성물
CN116801888A (zh) 用于结肠清洁的口服固体制剂
KR20180091572A (ko) 경구투여용 대장하제조성물
KR101093781B1 (ko) ｐＨ조절제를 함유하는 목시플록사신 고형 조성물
EP1880722B1 (en) Pharmaceutical compositions of ciprofloxacin
NZ207768A (en) Sustained release tablets comprising dipyridamole
US20150224056A1 (en) Pharmaceutical compositions of ibuprofen and famotidine
KR20250176963A (ko) 장정결을 위한 고형제제
KR102635438B1 (ko) 장 세척을 위한 고형제제 및 이의 제조방법
RU2483715C2 (ru) Твердая лекарственная форма препаратов мемантина и его солей

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241217

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241217

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250926

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250930

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260512

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260807